Management of Infective Endocarditis
What is Infective Endocarditis?
Infective endocarditis (IE) is a serious infection of the endocardium (the inner lining of the heart) and heart valves. It is most often of bacterial origin, more rarely fungal. Vegetations (clumps of fibrin, platelets, and microorganisms) form on the valves, leading to valve destruction (heart failure), septic emboli (brain, kidneys, spleen, lungs), and severe sepsis.
Infective endocarditis is a medical-surgical emergency with a life-threatening prognosis (mortality 20-30%). It requires prolonged antibiotic therapy (4 to 6 weeks) and often cardiac surgery (valve replacement or repair).
Types of Infective Endocarditis
- Acute endocarditis (evolving over days): highly virulent organisms (S. aureus, Streptococcus pyogenes, pneumococcus), rapid valve destruction, abscesses, septicemia, high mortality.
- Subacute endocarditis (evolving over weeks): less virulent organisms (Streptococcus viridans, enterococci, HACEK), insidious onset (fever, declining general condition, autoimmune signs).
- Prosthetic valve endocarditis (mechanical or bioprosthesis): early (< 1 year post-op) or late (> 1 year), nosocomial organisms (S. aureus, S. epidermidis, enterococci, fungi), extremely severe.
- Cardiac device-related endocarditis (pacemaker, defibrillator): infection of endocavitary leads.
- Right-sided endocarditis (tricuspid): often related to IV drug use (S. aureus), or central catheter.
What are the signs of Infective Endocarditis? (Symptoms)
Diagnosis is often delayed because symptoms are non-specific initially. The clinical presentation includes:
General Signs (constant)
- Prolonged fever (> 38-39°C): often the first sign, sometimes remittent or continuous.
- Chills, night sweats.
- Declining general condition: asthenia (fatigue), anorexia, weight loss (5-10% of body weight).
- Muscle pain, arthralgias.
Cardiac Signs
- Heart murmur (new or changed): most often regurgitation (aortic, mitral, tricuspid insufficiency).
- Acute or subacute heart failure: dyspnea (NYHA III-IV), orthopnea, lower limb edema, hepatomegaly.
- Rhythm disorders (atrial fibrillation, AV block) – sign of extension to the apex (septal abscess).
Peripheral Signs (septic emboli, vasculitis)
- Purpura, petechiae (conjunctival, palate, limbs).
- Osler's nodes: painful red nodules on finger pulps, toes.
- Janeway lesions: painless erythematous macules on palms, soles.
- Splinter hemorrhages (conjunctival).
- Splenomegaly (palpable spleen).
- Signs of visceral emboli: stroke (hemiplegia, aphasia), splenic infarct (left hypochondrium pain), renal infarct (hematuria, flank pain), pulmonary embolism (dyspnea, chest pain), peripheral embolism (acute limb ischemia).
- Autoimmune signs (subacute endocarditis): arthritis, glomerulonephritis (hematuria, proteinuria, AKI), Raynaud's syndrome.
Signs of Severity (require ICU management)
- Severe heart failure (pulmonary edema, cardiogenic shock).
- Septic shock (hypotension, vasopressors).
- Coma or major neurological deficit (massive cerebral embolism, cerebral hemorrhage from mycotic aneurysm rupture).
- Acute kidney injury (glomerulonephritis, septic AKI).
How is Infective Endocarditis Diagnosed in Tunisia?
Diagnosis is based on the Duke criteria (modified 2023), combining clinical, echocardiographic, and microbiological criteria.
Laboratory and Microbiological Tests (Major Criteria)
- Blood cultures (3 pairs, drawn from 3 different sites, before antibiotics): positive in 90-95% of endocarditis (if patient untreated). Sterile collection, 10-20 mL per bottle, incubation 5-7 days. Typical organisms: S. viridans, S. aureus, enterococci, streptococci, HACEK, coagulase-negative staphylococci (prostheses).
- PCR (16S rRNA) on valve (per-operative): if blood cultures negative (endocarditis due to Bartonella, Coxiella burnetii, Tropheryma whipplei, fungal).
- Serologies: Coxiella burnetii (Q fever), Bartonella, Legionella, Chlamydia, Mycoplasma.
- Inflammatory syndrome: elevated CRP (> 50-100 mg/L), elevated procalcitonin (especially bacterial), hyperleukocytosis, inflammatory anemia.
Echocardiography (Major Criteria)
- Transthoracic echocardiography (TTE): first-line exam, looks for vegetations (oscillating mass), septal abscess, valve regurgitation, mycotic aneurysm, valve perforation, chordae tendineae rupture, pericardial effusion. Sensitivity: 50-70%.
- Transesophageal echocardiography (TEE): reference exam if high suspicion or non-contributory TTE. Sensitivity > 90-95%, visualization of prostheses, annular abscesses, fistulas, vegetations < 5 mm. Performed under local anesthesia or sedation.
- 18F-FDG PET/CT: for prosthetic valve endocarditis (early) or suspected extracardiac abscess.
Major Criteria:
- Microbiological: positive blood cultures with typical endocarditis organism (x2) or with persistent organism (x2 at 12h interval) or positive PCR on valve.
- Echocardiographic: vegetations, abscess, pseudoaneurysm, fistula, prosthetic dehiscence, severe regurgitation.
Minor Criteria:
- Predisposition (heart disease, prosthesis, IV drug use).
- Fever ≥ 38°C.
- Vascular phenomena (emboli, mycotic aneurysm, conjunctival hemorrhage, purpura).
- Immunological phenomena (Osler's nodes, Janeway lesions, glomerulonephritis).
- Inconsistent or late positive blood cultures.
- Non-definitive TTE or TEE.
Additional Examinations
- Brain MRI: search for cerebral emboli (silent, asymptomatic) before surgery.
- Chest-abdominal CT scan: search for splenic, renal, hepatic emboli, abscesses.
- Fundoscopy: search for Roth spots (retinal hemorrhages).
- ECG: search for rhythm disorders (AF, AV block).
- 24-hour Holter ECG: if suspected silent coronary embolism.
How is Infective Endocarditis Managed in Tunisia?
Management is multidisciplinary (Endocarditis Team: cardiologist, infectious disease specialist, cardiac surgeon, intensivist).
Antibiotic Therapy (Empirical then Targeted)
Empirical antibiotic therapy (before blood culture results)
- Native valve (community): Amoxicillin (12 g/day IV) + Gentamicin (3 mg/kg/day IV) ± Ciprofloxacin if β-lactam allergy. Alternative: Vancomycin (30 mg/kg/day IV in 2-3 doses) + Gentamicin + Ciprofloxacin.
- Early prosthetic valve (< 1 year) or nosocomial: Vancomycin + Gentamicin + Ciprofloxacin or Rifampicin (900 mg/day IV/PO).
- Presumed S. aureus endocarditis (IV drug users, catheter): Oxacillin (12 g/day IV) or Vancomycin (if MRSA) + Gentamicin.
- Culture-negative endocarditis (blood cultures negative after 48-72h): cover Bartonella (doxycycline + gentamicin), Coxiella (doxycycline + hydroxychloroquine), fungi (amphotericin B, caspofungin).
Therapeutic monitoring: antibiotic levels (vancomycin, gentamicin, amikacin) to avoid nephrotoxicity/ototoxicity, CBC, creatinine (x2-3/week), audiogram (if gentamicin > 2 weeks).
Surgical Treatment (Valve Replacement or Repair)
Cardiac surgery is indicated in 30-50% of endocarditis cases, ideally after a few days of antibiotic therapy (except in emergencies).
Urgent Indications (< 24-48h):
- Severe refractory heart failure (pulmonary edema, cardiogenic shock).
- Recurrent septic emboli despite effective antibiotic therapy.
- Annular or septal abscess, fistula, sinus of Valsalva rupture.
- Fungal endocarditis.
- S. aureus prosthetic valve endocarditis with complications.
- Very mobile and large vegetations (> 10-15 mm) with high embolic risk.
Non-urgent Indications (1-2 weeks):
- Severe valve regurgitation (massive regurgitation) with progressive worsening.
- Antibiotic therapy failure (persistent blood cultures > 7-10 days).
- Prosthetic valve endocarditis with dehiscence or hemolysis.
- Asymptomatic cerebral mycotic aneurysm (to be discussed).
Surgical Procedures:
- Valve replacement (mechanical or bioprosthetic valve): for destroyed aortic, mitral, tricuspid valves.
- Valve repair (valvuloplasty): for mitral or tricuspid endocarditis (preserving the native valve).
- Vegetation and abscess debridement + reconstruction of septum and annulus.
- Removal of pacemaker/defibrillator leads (endocavitary or surgical extraction).
Intensive Care Management (Severe Forms)
- Septic shock: volume expansion (crystalloids 30 mL/kg), norepinephrine (MAP ≥ 65 mmHg), IV antibiotics, source control (surgery).
- Acute heart failure: diuretics (furosemide), dobutamine (inotrope), circulatory support (peri-operative ECMO).
- Acute kidney injury (AKI): continuous hemofiltration (CVVHDF).
- ARDS: protective mechanical ventilation (low TV, high PEEP), prone positioning.
- Post-embolic coma: neurological monitoring, brain CT/MRI, corticosteroids (if edema).
- Blood culture surveillance (24-48h) to verify sterilization.
Treatment of Embolic Complications
- Cerebral embolism (stroke): no anticoagulation if bleeding risk (mycotic aneurysm rupture). Neurosurgery if hematoma. Delay cardiac surgery by 2-4 weeks if possible.
- Mycotic aneurysm (infectious cerebral arterial dilation): endovascular treatment (coiling) or surgical, then deferred cardiac surgery.
- Splenic or renal embolism: monitoring, often asymptomatic. Splenectomy or nephrectomy if abscess or rupture.
- Pulmonary embolism: antibiotic therapy, no thrombectomy except in exceptional cases.
What are the Risks and Complications of Infective Endocarditis?
- Heart failure (30-50% of cases) – leading cause of death.
- Septic emboli (systemic): cerebral (20-40%), splenic (20-30%), renal (15-20%), pulmonary (right-sided endocarditis), coronary (heart attack), peripheral (acute limb ischemia).
- Annular abscess, septal abscess, fistula, sinus of Valsalva rupture (requires complex surgical repair).
- Mycotic aneurysm (cerebral, splenic, hepatic) – risk of hemorrhagic rupture.
- Glomerulonephritis (acute kidney injury) due to immune complexes.
- Disseminated intravascular coagulation (DIC).
- Septic shock, multiple organ dysfunction syndrome (MODS).
Prognosis of Infective Endocarditis
Hospital mortality is 20-30% (native valve) and up to 30-50% (prosthetic valve, S. aureus, cerebral complication). Unfavorable prognostic factors:
- Advanced age (> 70-80 years).
- Severe heart failure.
- Septic shock.
- Massive cerebral embolism.
- Antibiotic failure (> 7 days of persistent bacteremia).
- Annular abscess, fistula.
- Organism: S. aureus (mortality 30-50%), fungal (mortality 50-80%).
- Early prosthetic valve endocarditis (< 1 year).
What to Do After Infective Endocarditis?
- Regular cardiology follow-up: echocardiography at 1, 3, 6, 12 months, then annually.
- Clinical monitoring: fever, dyspnea, signs of embolism.
- Dental prophylaxis (antibiotic prophylaxis) for high-risk procedures (extraction, scaling) in patients with prosthetic valves, history of endocarditis, unrepaired congenital heart disease, valve repair within 6 months.
- Rigorous dental care (treatment of cavities, periodontitis).
- Avoid piercings, tattoos, IV drugs.
- Anticoagulant therapy (VKA or DOAC) if mechanical valve or atrial fibrillation.
Why Choose Tunisia for Infective Endocarditis Management?
Tunisia has high-level cardiologists, infectious disease specialists, and cardiac surgeons, trained in the best European centers (Paris, Lyon, Marseille, Montpellier, Geneva, Brussels). Diagnostic and therapeutic equipment is modern: echocardiography (TTE/TEE), automated blood cultures, PCR laboratory, catheterization laboratory, cardiac surgery operating room with cardiopulmonary bypass, cardiac surgery ICU.
Advantages of Tunisia:
- Transesophageal echocardiography (TEE) performed within the day (no delay).
- Prolonged antibiotic therapy (4-6 weeks) as inpatient or outpatient (oral switch).
- Cardiac surgery (valve replacement) under cardiopulmonary bypass available in university hospitals and private clinics.
- Compliance with ESC (European Society of Cardiology) 2023 guidelines.
- All-inclusive packages (hospitalization + antibiotic therapy + echocardiograms + blood cultures + surgery if applicable).
- Management of foreign patients: simplified formalities, coordination with insurance companies, multilingual reception in French, English, Arabic, Italian.